LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer

BACKGROUND: The purpose of this study is to develop an effective but concise long non-coding RNA (lncRNA) expression signature that can predict response to neoadjuvant chemotherapy for breast cancer (BC) patients. METHODS: lncRNA expression profiling in 1102 BC patients from Gene Expression Omnibus...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Ying, Wang, Guo, Zhou, Cheng-Fang, Zhang, Hai-Bo, Sun, Hong, Zhang, Wei, Zhou, Hong-Hao, Liu, Rong, Zhu, Yuan-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546925/
https://www.ncbi.nlm.nih.gov/pubmed/31191314
http://dx.doi.org/10.3389/fphar.2019.00574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546925/
https://www.ncbi.nlm.nih.gov/pubmed/31191314
http://dx.doi.org/10.3389/fphar.2019.00574

Ejemplares similares